• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性戊型肝炎导致 HIV 相关隐源性肝硬化。

Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV.

机构信息

HIV & Sexual Health Department, Chelsea and Westminster Hospital, London, United Kingdom.

出版信息

J Infect. 2013 Jan;66(1):103-6. doi: 10.1016/j.jinf.2011.11.027. Epub 2011 Dec 6.

DOI:10.1016/j.jinf.2011.11.027
PMID:22166370
Abstract

Chronic Hepatitis E infection (HEV) is reported in immunocompromised patients. A 45-year-old HIV-infected man had no cause found for a persistent transaminitis which predated commencement of antiretroviral therapy. Hepatic elastography and liver biopsy revealed cirrhosis. In 2010, he tested positive for HEV IgM/IgG antibodies. Plasma HEV RNA was detected. Archived samples revealed HEV viraemia since 2000. A 24-week course of pegylated interferon was commenced and HEV RNA became undetectable at week 4 until week 27 post treatment cessation. Chronic HEV infection should be considered in HIV patients as a cause for unexplained transaminitis and cryptogenic liver cirrhosis.

摘要

慢性戊型肝炎病毒(HEV)感染在免疫功能低下的患者中已有报道。一名 45 岁的 HIV 感染者在开始接受抗逆转录病毒治疗之前,其持续性转氨升高的原因不明。肝弹性成像和肝活检显示为肝硬化。2010 年,他的 HEV IgM/IgG 抗体检测呈阳性。检测到血浆 HEV RNA。存档样本显示自 2000 年以来一直存在 HEV 病毒血症。开始了 24 周的聚乙二醇干扰素治疗,在治疗停止后的第 4 周到第 27 周,HEV RNA 检测不到。在 HIV 患者中,不明原因的转氨升高和隐匿性肝硬化应考虑慢性 HEV 感染。

相似文献

1
Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV.慢性戊型肝炎导致 HIV 相关隐源性肝硬化。
J Infect. 2013 Jan;66(1):103-6. doi: 10.1016/j.jinf.2011.11.027. Epub 2011 Dec 6.
2
Treatment of chronic hepatitis E in a patient with HIV infection.慢性戊型肝炎合并 HIV 感染患者的治疗。
Ann Intern Med. 2011 Oct 4;155(7):479-80. doi: 10.7326/0003-4819-155-7-201110040-00017.
3
Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.肝移植后慢性戊型肝炎病毒感染:抗病毒治疗后纤维化的消退
Transplantation. 2017 Sep;101(9):2083-2087. doi: 10.1097/TP.0000000000001766.
4
Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.原位肝移植后单用利巴韦林成功治疗慢性戊型肝炎
Exp Clin Transplant. 2015 Jun;13(3):283-6. doi: 10.6002/ect.2013.0286. Epub 2014 Apr 28.
5
Prevalence of antibodies and RNA genome of hepatitis E virus in a cohort of French immunocompromised.在法国免疫功能低下人群的队列中,戊型肝炎病毒抗体和 RNA 基因组的流行率。
J Clin Virol. 2012 Apr;53(4):346-9. doi: 10.1016/j.jcv.2012.01.001. Epub 2012 Jan 30.
6
Hepatitis E virus infection in patients infected with the human immunodeficiency virus.戊型肝炎病毒感染在感染人类免疫缺陷病毒的患者中。
J Med Virol. 2011 Oct;83(10):1704-16. doi: 10.1002/jmv.22177.
7
[Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].[器官移植受者中的慢性戊型肝炎病毒感染与治疗]
Bing Du Xue Bao. 2015 May;31(3):293-8.
8
Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.聚乙二醇干扰素-α治疗肝移植后慢性戊型肝炎病毒感染。
Clin Infect Dis. 2010 Mar 1;50(5):e30-3. doi: 10.1086/650488.
9
Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.HIV 感染者的慢性戊型肝炎:迅速进展为肝硬化和对口服利巴韦林的反应。
Clin Infect Dis. 2013 Aug;57(3):465-8. doi: 10.1093/cid/cit224. Epub 2013 Apr 10.
10
Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient.受体接受隐匿性 HEV 感染供体的肝移植后引发慢性肝炎和肝硬化。
J Hepatol. 2012 Feb;56(2):500-2. doi: 10.1016/j.jhep.2011.06.021. Epub 2011 Jul 26.

引用本文的文献

1
Clinical Characteristics and Epidemiological Features of Hepatitis E Virus Infection Among People Living with HIV in Shanghai, China.中国上海HIV感染者中戊型肝炎病毒感染的临床特征与流行病学特征
Viruses. 2025 Jul 25;17(8):1038. doi: 10.3390/v17081038.
2
Systematic Evaluation of Guidelines for the Diagnosis and Treatment of Hepatitis E Virus Infection.戊型肝炎病毒感染诊断和治疗指南的系统评价
J Clin Transl Hepatol. 2024 Aug 28;12(8):739-749. doi: 10.14218/JCTH.2023.00508. Epub 2024 Jun 28.
3
Comparative Analysis on Clinical Characteristics Among Patients with Acute Hepatitis A Virus (HAV) and Patients with Acute Hepatitis E Virus (HEV): A Single-Center Retrospective Study from Bulgaria.
甲型肝炎病毒(HAV)急性感染患者与戊型肝炎病毒(HEV)急性感染患者临床特征的比较分析:一项来自保加利亚的单中心回顾性研究
Infect Drug Resist. 2023 May 29;16:3349-3366. doi: 10.2147/IDR.S411606. eCollection 2023.
4
Treatment Options for Hepatitis A and E: A Non-Systematic Review.甲型和戊型肝炎的治疗选择:非系统性综述。
Viruses. 2023 Apr 28;15(5):1080. doi: 10.3390/v15051080.
5
Transmission of Hepatitis E Virus.戊型肝炎病毒传播。
Adv Exp Med Biol. 2023;1417:73-92. doi: 10.1007/978-981-99-1304-6_6.
6
Shear wave elastography-based liver fibrosis assessment in patients with chronic hepatitis E displays elevated liver stiffness regardless of previous antiviral therapy.基于剪切波弹性成像的慢性戊型肝炎患者肝纤维化评估显示,无论先前是否接受抗病毒治疗,肝脏硬度均升高。
Quant Imaging Med Surg. 2022 Jul;12(7):3528-3538. doi: 10.21037/qims-21-1178.
7
Hepatitis E in immunocompromised individuals.免疫功能低下个体中的戊型肝炎
World J Hepatol. 2022 Mar 27;14(3):482-494. doi: 10.4254/wjh.v14.i3.482.
8
Viral hepatitis: Innovations and expectations.病毒性肝炎:创新与展望。
World J Gastroenterol. 2022 Feb 7;28(5):517-531. doi: 10.3748/wjg.v28.i5.517.
9
Hepatitis E Virus: An emerging enigmatic and underestimated pathogen.戊型肝炎病毒:一种新出现的神秘且被低估的病原体。
Saudi J Biol Sci. 2022 Jan;29(1):499-512. doi: 10.1016/j.sjbs.2021.09.003. Epub 2021 Sep 20.
10
Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma.超乎常见病因:戊型肝炎病毒及其在肝细胞癌中的意义
Cancers (Basel). 2021 Nov 22;13(22):5867. doi: 10.3390/cancers13225867.